- Home
- CELC vs YETI Comparison
CELC vs YETI Comparison
Compare CELC & YETI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- YETI
- Stock Information
- Founded
- CELC 2011
- YETI 2006
- Country
- CELC United States
- YETI United States
- Employees
- CELC N/A
- YETI N/A
- Industry
- CELC Medical Specialities
- YETI Recreational Games/Products/Toys
- Sector
- CELC Health Care
- YETI Consumer Discretionary
- Exchange
- CELC Nasdaq
- YETI Nasdaq
- Market Cap
- CELC 3.1B
- YETI 2.7B
- IPO Year
- CELC 2017
- YETI 2018
- Fundamental
- Price
- CELC $100.23
- YETI $41.98
- Analyst Decision
- CELC Strong Buy
- YETI Buy
- Analyst Count
- CELC 7
- YETI 12
- Target Price
- CELC $95.29
- YETI $38.45
- AVG Volume (30 Days)
- CELC 916.2K
- YETI 2.4M
- Earning Date
- CELC 11-12-2025
- YETI 11-06-2025
- Dividend Yield
- CELC N/A
- YETI N/A
- EPS Growth
- CELC N/A
- YETI N/A
- EPS
- CELC N/A
- YETI 1.93
- Revenue
- CELC N/A
- YETI $1,831,326,000.00
- Revenue This Year
- CELC N/A
- YETI $3.23
- Revenue Next Year
- CELC N/A
- YETI $5.13
- P/E Ratio
- CELC N/A
- YETI $21.55
- Revenue Growth
- CELC N/A
- YETI 1.56
- 52 Week Low
- CELC $7.58
- YETI $26.61
- 52 Week High
- CELC $103.06
- YETI $45.25
- Technical
- Relative Strength Index (RSI)
- CELC 78.25
- YETI 72.46
- Support Level
- CELC $92.10
- YETI $35.83
- Resistance Level
- CELC $103.06
- YETI $39.06
- Average True Range (ATR)
- CELC 5.52
- YETI 1.56
- MACD
- CELC 0.74
- YETI 0.52
- Stochastic Oscillator
- CELC 90.84
- YETI 98.77
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.